Bilcare Ltd (BI)

📊 Quarterly Results (₹ Cr)

The company swung from a ₹23 crore net loss in Sep 2025 to a ₹15 crore profit in Jun 2026, marking its first profitable quarter in over a year. This improvement aligns with management’s stated focus on margin recovery, as OPM rose sharply to 14.6% from negative 4.9% a quarter earlier. However, revenue remains below pre-crisis levels, and profitability is still inconsistent, with operating losses persisting through much of FY25.

🔮 Management Outlook & What's Next

In the Q1FY27 results commentary, management expressed cautious optimism, citing stabilizing customer demand and ongoing efficiency initiatives. Forward guidance emphasized sustained focus on working capital management and incremental margin expansion, with no specific revenue growth targets disclosed. No long-term financial targets were provided, reflecting the uncertain macro environment and ongoing restructuring.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet shows a significant reduction in net worth, with equity and reserves declining from ₹469 crore (Mar 2025) to ₹24 crore (Mar 2026), while borrowings remain elevated at ₹620 crore. This suggests aggressive capital erosion and limited internal financing capacity. Despite asset growth historically, recent asset base contraction indicates potential write-downs or deferred investments, raising concerns about long-term solvency without a durable earnings recovery.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Promoter holding remains stable at 30.01%, with no signs of dilution or pledge. However, institutional interest is negligible — FII and DII holdings are flat near zero, and the number of public shareholders has slightly declined. This lack of institutional accumulation suggests limited confidence from broader markets, despite the recent profit rebound.

⚖️ Peer Comparison — Packaging

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Persistent negative ROE (-1.4%) and weak ROCE (5.7%) indicate capital is not being used efficiently, even during recovery phases. 2. High debt-to-equity (1.43) combined with volatile earnings increases financial vulnerability, especially if margins compress again. 3. Management has not provided a clear turnaround roadmap or timeline for sustainable profitability, leaving execution risks unquantified. 4. Low institutional ownership and stagnant public float suggest limited market confidence, which could amplify volatility on any negative development.

📋 Recent Filings

• 🟡 Board Meeting2026-09-29Bilcare Limited held its 39th Annual General Meeting on 26 September 2026 via video conferencing, with 38 shareholders participating remotely. Shareho…
• Announcement2026-09-28Bilcare Limited announced that its trading window for securities will close on 1 October 2026, remaining shut until 48 hours after the unaudited finan…
• 🟡 Board Meeting2026-09-26Bilcare held its 39th AGM on 26 September 2026 via video conference, with 38 shareholders present. All directors, auditors and officials attended remo…
• 🟡 Board Meeting2026-09-24Bilcare corrected a clerical error in its AGM notice, clarifying that Item No. 4 appointing Mr. Mohan Bhandari as a Director is an Ordinary Resolution…
• 🟡 Board Meeting2026-09-24Bilcare corrected a clerical error in its AGM notice, clarifying that Item No. 4 appointing Mr. Mohan Bhandari as a Director is an Ordinary Resolution…
• 🔴 annual report2026-09-04Bilcare Ltd announced director appointments for 3-year terms until 2029 at its 39th AGM on 26 September 2026, alongside filing its Annual Report 2025-…
• 🔴 annual report2026-09-04Bilcare Ltd announced board appointments of Mohan Bhandari and Kavita Bhansali effective August 2026, alongside filing its FY2025-26 annual report sho…
• 🟡 Board Meeting2026-09-04Bilcare Limited announced the outcome of its 04 September 2026 board meeting, approving changes to director appointments including reduced terms for M…

🧠 Analyst's Read

Bilcare is in a delicate recovery phase with early signs of operational improvement but lacks the financial depth and market confidence to sustain momentum. Investors should monitor quarterly margin trends and any shift in capital allocation strategy, particularly around debt reduction or reinvestment, as key indicators of long-term viability.

Based on filing content and financial data. Not a recommendation.